Localization of the Reward Positivity to ACC
Primary Purpose
Refractory Epilepsy
Status
Recruiting
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
Virtual T-maze task
Sponsored by
About this trial
This is an interventional basic science trial for Refractory Epilepsy focused on measuring Anterior Cingulate Cortex, Reward positivity
Eligibility Criteria
Inclusion Criteria:
- Age 18 years or older
- Patients with refractory epilepsy
- Planned hospitalization at CNM for invasive video-EEG recording with subdural, epidural and/or depth electrodes
- Patients have to be able to give informed consent themselves
- Imaging after placement of electrodes (CT and/or MRI) has to be available
Exclusion Criteria:
- Patients known with dementia or severe cognitive and/or psychiatric disorders that makes it impossible for patients to participate in this study
- Active alcohol and/or drug abuse
Sites / Locations
- Department of Neurology, University Hospital GhentRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Intervention group
Arm Description
Each participant will undergo two sessions, consisting of performing the virtual T-maze task, scalp-EEG recording and/or intracranial video-EEG recording.
Outcomes
Primary Outcome Measures
Distribution of reward positivity amplitude
Calculation of amplitude of reward positivity ERP-component recorded by intracranial electrodes and scalp-distribution of amplitude across all subjects
Secondary Outcome Measures
Location in brain most likely to represent source of reward positivity
Electrode with highest reward positivity amplitude and corresponding location in brain, analysis across all subjects
Full Information
NCT ID
NCT04684797
First Posted
December 21, 2020
Last Updated
January 3, 2023
Sponsor
University Hospital, Ghent
Collaborators
University Ghent
1. Study Identification
Unique Protocol Identification Number
NCT04684797
Brief Title
Localization of the Reward Positivity to ACC
Official Title
Localization of the Reward Positivity to ACC
Study Type
Interventional
2. Study Status
Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 4, 2021 (Actual)
Primary Completion Date
September 2024 (Anticipated)
Study Completion Date
September 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Ghent
Collaborators
University Ghent
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The exact function of the anterior cingulate cortex (ACC) is one of the largest riddles in cognitive neuroscience and a major challenge in mental health research. ACC dysfunction contributes to a broad spectrum of neurological and psychiatric disorders, such as depression, ADHD, Parkinson's disease, OCD and many others, but nobody knows what it actually does. Recently a new theory has been developed about ACC function; the HRL-ACC (Hierarchical Reinforcement Learning Theory of ACC). This theory proposes that the ACC selects and motivates high-level tasks based on the principles of hierarchical reinforcement learning. The ACC associates values with tasks, selects the correct tasks and applies control over other neural networks (such as the dorsolateral prefrontal cortex and basal ganglia), which execute the tasks. The values of these tasks are attributed based on "reward prediction error signals", which are sent from the midbrain dopamine system to the ACC. These signals can be recorded using scalp-EEG as an "event-related brain potential" (ERP), which is called the "reward positivity". Until this day, the exact origin of the reward positivity is not yet known. Studies have delivered strong indirect evidence that the reward positivity is generated in the ACC. However, there is an important lack of direct evidence to support this hypothesis. The goal of this study is to provide direct evidence that the reward positivity is generated in the ACC by letting a group of patients with refractory epilepsy perform the virtual T-maze task (which is known to elicit reward positivity) and simultaneously recording intracranial video-EEG.
Detailed Description
This is a monocentric prospective interventional clinical trial that will include patients with refractory epilepsy and for whom a hospitalization at the Centre for Neurophysiological Monitoring (CNM) at the University Hospital Ghent is planned for invasive video-EEG recording. This hospitalization is part of a pre-surgical work-up to determine if the patient is eligible for resective surgery. It is important to note that the decision to plan the patient for invasive video-EEG monitoring is made by neurologists and neurosurgeons specialized in refractory epilepsy and is in no way connected to this study.
Every patient that will be admitted to the CNM for invasive video-EEG monitoring has a consultation with Prof. Dr. Alfred Meurs about one month before hospitalization. During this consultation, Prof. Meurs will ask if the patient is willing to participate in this study. If the patient agrees and has given informed consent, the first session of the study will take place directly after the consultation. However, if the patient is not available at that time, a new appointment will be made for the first session. The first session has to take place before admission to the CNM.
The study consists of two experimental sessions. The first session takes place after giving informed consent and before admission to the hospital for invasive video-EEG monitoring. Therefore, this session is completely study-specific and may require and extra visit to the hospital if the patient is not available right after the consultation with Prof. Meurs.
During this session, the patient will perform the virtual T-maze task for 20 minutes while scalp-EEG will be recorded simultaneously. During this task, patients will see a T-maze on a computer screen and have to choose at every junction whether they go left or right. Depending on the direction they choose, they get rewarded or not. This feedback will elicit the reward positivity.
The rationale for this first session is that it is important to know whether or not the patient produces a normal reward positivity measured by scalp EEG, before the intracranial electrodes are placed.
The second session takes place during the admission at the CNM, after the intracranial electrodes are placed. The invasive video-EEG monitoring is part of a pre-surgical work-up and is planned independently from the study. During this session, the patient will once again have to perform the virtual T-maze task while scalp-EEG and intracranial-EEG will simultaneously be recorded.
After the two sessions, the data will be analysed using ERP analysis and the amplitude of the reward positivity will be calculated for every electrode. It is expected that the amplitude of the reward positivity ERP-component will be largest for patients with electrodes in the frontal lobe, located closely to the ACC. This will deliver direct evidence that the reward positivity is in fact generated in the ACC.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Refractory Epilepsy
Keywords
Anterior Cingulate Cortex, Reward positivity
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
40 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Intervention group
Arm Type
Experimental
Arm Description
Each participant will undergo two sessions, consisting of performing the virtual T-maze task, scalp-EEG recording and/or intracranial video-EEG recording.
Intervention Type
Behavioral
Intervention Name(s)
Virtual T-maze task
Intervention Description
Patients will have to perform the virtual T-maze task, which is known to elicit reward positivity. During this task, the patients will see a virtual T-maze on a computer screen and have to choose at every junction whether they go right or left. Depending on the direction they choose, they either get positive or negative feedback (reward or no reward). This feedback is chosen completely at random, on a 50% reward/50% no reward basis.
Primary Outcome Measure Information:
Title
Distribution of reward positivity amplitude
Description
Calculation of amplitude of reward positivity ERP-component recorded by intracranial electrodes and scalp-distribution of amplitude across all subjects
Time Frame
Date of inclusion to date of second session (about one month)
Secondary Outcome Measure Information:
Title
Location in brain most likely to represent source of reward positivity
Description
Electrode with highest reward positivity amplitude and corresponding location in brain, analysis across all subjects
Time Frame
Date of inclusion to date of second session (about one month)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age 18 years or older
Patients with refractory epilepsy
Planned hospitalization at CNM for invasive video-EEG recording with subdural, epidural and/or depth electrodes
Patients have to be able to give informed consent themselves
Imaging after placement of electrodes (CT and/or MRI) has to be available
Exclusion Criteria:
Patients known with dementia or severe cognitive and/or psychiatric disorders that makes it impossible for patients to participate in this study
Active alcohol and/or drug abuse
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Alfred Meurs, MD PhD
Phone
+3293326482
Email
alfred.meurs@ugent.be
First Name & Middle Initial & Last Name or Official Title & Degree
Joyce Oerlemans
Phone
+3293325607
Email
joyce.oerlemans@ugent.be
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alfred Meurs, MD PhD
Organizational Affiliation
University Hospital Ghent, Department of Neurology
Official's Role
Principal Investigator
Facility Information:
Facility Name
Department of Neurology, University Hospital Ghent
City
Ghent
State/Province
Oost-Vlaanderen
ZIP/Postal Code
9000
Country
Belgium
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Joyce Oerlemans
Phone
+3293325607
Email
joyce.oerlemans@ugent.be
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Localization of the Reward Positivity to ACC
We'll reach out to this number within 24 hrs